Alternative Splicing as a Prognostic Determinant in Colorectal Cancer: An Integrated Multi-Omics Analysis

Background: Colorectal cancer (CRC) exhibits substantial inter-patient heterogeneity in clinical outcomes. Despite this, prognostic stratification tools are limited although multi-omics studies have tried to identify biomarkers for patient discrimination. Alternative splicing represents a major source of transcriptomic diversity in CRC, but its use in biomarker development remains limited. The present study aimed to characterize the prognostic alternative splicing landscape of CRC through an integrated multi-omics framework. Methods: Percent spliced-in (PSI) values for colon and rectal cancers were obtained from TCGASpliceSeq database. Of 1000 high-variance splicing events initially selected, 971 events that met quality filters were evaluated using univariate Cox proportional hazards regression to identify candidate prognostic events followed by construction of a LASSO-Cox multi-feature prognostic signature, which was cross-validated. The prognostic relevance of selected splicing-associated genes was evaluated in three independent cohorts (GSE17538, GSE72970, GSE39582) totaling 875 patients. The biological context of candidate splicing events was characterized through competing risk analysis, mutation-splicing regulatory mapping, and tumor immune microenvironment profiling. Results: Twenty candidate prognostic splicing events were identified based on unadjusted p-values, as no event survived FDR correction; these represent exploratory candidates with a substantial risk of false-positive associations. The exon-skipping event showed the highest mean hazard ratio among the five event types. The LASSO-Cox signature showed moderate time-dependent discrimination in the TCGA discovery cohort (cross-validated C-index 0.586). Gene-level expression of the 20 splicing-associated genes showed consistent prognostic stratification across all three independent cohorts, providing supportive but indirect evidence of prognostic relevance. A total of 322 mutation-splicing associations remained significant after multiple-testing correction (FDR < 0.05). NTMT1 and MAST1 showed a significant correlation with immune infiltration. Conclusions: The study presents a multi-cohort exploratory analysis of alternative splicing as a potential prognostic marker for CRC. Twenty candidate events identified based on unadjusted p-values should be considered as preliminary candidates for further investigation.

Authors

Institutions

Publication Details

Journal
Onco
Published
2026-11-18
DOI
https://doi.org/10.3390/onco6040056
Primary Topic
RNA Research and Splicing
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Alternative Splicing as a Prognostic Determinant in Colorectal Cancer: An Integrated Multi-Omics Analysis

Devi Lal, Himani Pandey
Onco
RNA Research and Splicing
article

Alternative Splicing as a Prognostic Determinant in Colorectal Cancer: An Integrated Multi-Omics Analysis

Devi Lal, Himani Pandey
article en

Abstract

Background: Colorectal cancer (CRC) exhibits substantial inter-patient heterogeneity in clinical outcomes. Despite this, prognostic stratification tools are limited although multi-omics studies have tried to identify biomarkers for patient discrimination. Alternative splicing represents a major source of transcriptomic diversity in CRC, but its use in biomarker development remains limited. The present study aimed to characterize the prognostic alternative splicing landscape of CRC through an integrated multi-omics framework. Methods: Percent spliced-in (PSI) values for colon and rectal cancers were obtained from TCGASpliceSeq database. Of 1000 high-variance splicing events initially selected, 971 events that met quality filters were evaluated using univariate Cox proportional hazards regression to identify candidate prognostic events followed by construction of a LASSO-Cox multi-feature prognostic signature, which was cross-validated. The prognostic relevance of selected splicing-associated genes was evaluated in three independent cohorts (GSE17538, GSE72970, GSE39582) totaling 875 patients. The biological context of candidate splicing events was characterized through competing risk analysis, mutation-splicing regulatory mapping, and tumor immune microenvironment profiling. Results: Twenty candidate prognostic splicing events were identified based on unadjusted p-values, as no event survived FDR correction; these represent exploratory candidates with a substantial risk of false-positive associations. The exon-skipping event showed the highest mean hazard ratio among the five event types. The LASSO-Cox signature showed moderate time-dependent discrimination in the TCGA discovery cohort (cross-validated C-index 0.586). Gene-level expression of the 20 splicing-associated genes showed consistent prognostic stratification across all three independent cohorts, providing supportive but indirect evidence of prognostic relevance. A total of 322 mutation-splicing associations remained significant after multiple-testing correction (FDR < 0.05). NTMT1 and MAST1 showed a significant correlation with immune infiltration. Conclusions: The study presents a multi-cohort exploratory analysis of alternative splicing as a potential prognostic marker for CRC. Twenty candidate events identified based on unadjusted p-values should be considered as preliminary candidates for further investigation.

OncoVol. 6(4)
University of Delhi (IN)
Good health and well-being
RNA Research and Splicing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon